jeudi 29 novembre 2018

Onco Actu du 29 novembre 2018

1.4 Biologie - Technos

Chinese Researcher Reports First Gene-Edited Babies [Science-Based Medicine]

Ethics aside, does the CRISPR baby experiment make scientific sense? [Science]

3.1.1 Prévention - Tabac - e-cigs

Juul’s New Product: Less Nicotine, More Intense Vapor [NY Times]

4.7 Dép., diag. & prono. - Col de l'utérus

At-home HPV tests could be powerful tool for hard-to-reach U.S. women [OSU]

4.9 Dép., diag. & prono. - Sein

New Study Supports Mammography Screening at 30 for Some Women [RSNA]

5. Traitements

Malignancy, MSI Status, and the Microbiome [Cancer Research Catalyst]

5.1 Traitements - Pré-clinique

Altering cancer metabolism helps treatments attack tumours [Cancer Research UK]

5.10 Traitements - Essais

Statistical pitfalls of personalized medicine [Nature]

5.12 Immunothérapies

Brain Cancer Immunotherapy SurVaxM Extends Survival, Even in Hard-to-Treat Patients [Roswell Park]

5.12.1 Immunothérapies - partenariats

Hookipa tasks DarwinHealth with finding shared tumor antigens [FierceBiotech]

5.12.8 Immunothérapies - Economie

Merck raised prices five drugs including Keytruda in November [Reuters]

5.2.1 Pharma - Partenariats

Biocartis partners with AstraZeneca on lung cancer diagnostics [Reuters]

5.3.4 Traitements - AMM (FDA, EMA,...)

FDA stamps fast OK on Astellas’ pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals [EndPoints]

XOSPATA® (gilteritinib) Approved by U.S. FDA for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) with a FLT3 Mutation [Astellas]

Astellas Pharma gets U.S. nod for blood cancer treatment [Reuters]

FDA approves first biosimilar to Roche cancer drug Rituxan [Reuters]

FDA approves first biosimilar for treatment of adult patients with non-Hodgkin’s lymphoma [FDA]

FDA approves treatment for adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a certain genetic mutation [FDA]

5.4 Traitements - Economie

Bayer’s Stivarga wins NICE backing for advanced liver cancer [PharmaTimes]

Compromising Patient Protections to Lower Drug Costs Could Harm People with Cancer [ASCO]

5.8 ASH

ASH Webinar: Pre-Meeting Peek at Key Presentations from ASH 2018 [OBR]

6.1 Observation

Cancer diagnosis tied to increased suicide risk [Reuters]

6.11 Patients

Nancy Cappello, Breast Cancer Activist, Is Dead at 66 [NY Times]

6.6 Publications

Transparent peer review trial: the results [Genome Biology]

6.7.1 IA/bioinformatique

Big Tech Expands Footprint in Health [Wall Street Journal]

Introducing medical language processing with Amazon Comprehend Medical [AWS]

6.8 Communication

Reliance on 'YouTube Medicine' May Be Dangerous for Those Concerned About Prostate Cancer [NYU Langone]

Popular prostate cancer videos on YouTube 'inaccurate and biased' [NHS Choices]

Online Cancer Information Is Often Unreliable [NY Times]